WallStreetZenWallStreetZen

NASDAQ: PHAT
Phathom Pharmaceuticals Inc Stock Ownership - Who owns Phathom Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Phathom Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Molly HendersonCFO and CBO2025-04-073,678$4.55
$16.74kSell
Asit ParikhDirector2025-03-1310,000$4.42
$44.20kBuy
Azmi NabulsiChief Operating Officer2025-01-217,886$6.59
$51.95kSell
Terrie CurranPresident and Chief Executive2025-01-2119,109$6.59
$125.89kSell
Molly HendersonCFO and CBO2025-01-216,583$6.59
$43.37kSell
Molly HendersonCFO and CBO2024-12-191,291$8.00
$10.33kSell
Azmi NabulsiChief Operating Officer2024-12-191,118$8.00
$8.94kSell
Frank KarbeDirector2024-12-1312,500$7.93
$99.09kBuy
Asit ParikhDirector2024-12-1310,000$8.13
$81.25kBuy
Asit ParikhDirector2024-09-107,500$11.72
$87.90kBuy

1 of 2

PHAT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PHAT insiders and whales buy or sell their stock.

PHAT Shareholders

What type of owners hold Phathom Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP14.52%10,109,279$39.43MInstitution
Medicxi Ventures Management Jersey Ltd10.72%7,464,572$29.11MInsider
Medicxi Ventures Management Jersey Ltd10.72%7,464,572$29.11MInstitution
Jennison Associates LLC10.14%7,062,507$27.54MInstitution
James N. Topper8.42%5,863,423$22.87MInsider
Frazier Life Sciences IX LP8.39%5,842,352$22.79MInsider
Takeda Pharmaceutical Co Ltd5.39%3,755,583$14.65MInsider
Invesco Ltd5.27%3,671,386$14.32MInstitution
Blackrock Inc5.03%3,502,375$13.66MInstitution
Carlyle Group Inc5.02%3,496,808$13.64MInstitution

1 of 3

PHAT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PHAT67.34%32.66%Net SellingNet Buying
XOMA18.57%81.43%Net SellingNet Selling
CMPX71.31%28.69%Net SellingNet Selling
ALMS69.03%30.97%Net BuyingNet Buying
LSB0.20%0.00%
View Top Biotech Stocks

Phathom Pharmaceuticals Stock Ownership FAQ

Who owns Phathom Pharmaceuticals?

Phathom Pharmaceuticals (NASDAQ: PHAT) is owned by 95.75% institutional shareholders, 46.43% Phathom Pharmaceuticals insiders, and 0.00% retail investors. Medicxi Ventures Management Jersey Ltd is the largest individual Phathom Pharmaceuticals shareholder, owning 7.46M shares representing 10.72% of the company. Medicxi Ventures Management Jersey Ltd's Phathom Pharmaceuticals shares are currently valued at $29.56M.

If you're new to stock investing, here's how to buy Phathom Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.